•
Jun 30, 2020

Cassava Sciences Q2 2020 Earnings Report

Announced financial results for the second quarter ended June 30, 2020 and provided a mid-year business review.

Key Takeaways

Cassava Sciences reported a net loss of $1.1 million, or $0.05 per share, for the second quarter ended June 30, 2020. The company's cash and cash equivalents were $25.3 million as of June 30, 2020, with no debt.

Net loss was $1.1 million, or $0.05 per share, compared to a net loss of $1.1 million, or $0.06 per share, for the same period in 2019.

Net cash used in operations was $2.0 million during the first six months of 2020.

Net cash use in full-year 2020 is still expected to be approximately $5.0 million.

Cash and cash equivalents were $25.3 million as of June 30, 2020, with no debt.

Total Revenue
$0
0
EPS
-$0.05
Previous year: -$0.06
-16.7%
Cash and Equivalents
$25.3M

Cassava Sciences

Cassava Sciences